Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentprotein complex involved in cell adhesion

ITGAD ITGAM ITGAV LGALS1 NID1

6.12e-05591485GO:0098636
HumanPhenoAbnormal urine cytology

ACP5 ETS1 ITGAM LMAN1 ALG9 AGXT PKD1 CD81 CLDN19

4.24e-05188479HP:0012614
HumanPhenoHematuria

ACP5 ETS1 ITGAM LMAN1 ALG9 AGXT PKD1 CD81 CLDN19

4.24e-05188479HP:0000790
MousePhenonephrocalcinosis

PTGS2 KL ATP6V0A4 AGXT

1.77e-05201134MP:0003197
Domain6-blade_b-propeller_TolB-like

NID2 APEH NID1 EIF3B SORL1

2.79e-05461455IPR011042
DomainGlycoside_hydrolase_SF

AMY2A GBE1 KL FUCA2 OGA

5.60e-05531455IPR017853
DomainTransform_prot_C-ets

ETS1 ETS2

5.99e-0521452IPR016311
DomainNLGN4

NLGN4Y NLGN4X

5.99e-0521452IPR030025
DomainIntegrin_alpha

ITGAD ITGAM ITGAV

7.23e-05111453PF00357
Domain-

AMY2A GBE1 KL FUCA2

1.51e-043514543.20.20.80
Domain-

AMY2A GBE1 FUCA2

1.57e-041414532.60.40.1180
DomainLdl_recept_b

NID2 NID1 SORL1

1.57e-04141453PF00058
DomainLDLRB

NID2 NID1 SORL1

1.57e-04141453PS51120
DomainPeptidase_S28

DPP7 PRCP

1.79e-0431452IPR008758
DomainBH4

BCL2 BCL2L2

1.79e-0431452PF02180
DomainG2F

NID2 NID1

1.79e-0431452SM00682
DomainBcl2_BH4_motif_CS

BCL2 BCL2L2

1.79e-0431452IPR020731
DomainBH4

BCL2 BCL2L2

1.79e-0431452SM00265
DomainPeptidase_S28

DPP7 PRCP

1.79e-0431452PF05577
DomainLY

NID2 NID1 SORL1

1.95e-04151453SM00135
DomainGlyco_hydro_b

AMY2A GBE1 FUCA2

1.95e-04151453IPR013780
DomainLDLR_classB_rpt

NID2 NID1 SORL1

1.95e-04151453IPR000033
DomainGlyco_hydro_catalytic_dom

AMY2A GBE1 KL FUCA2

2.10e-04381454IPR013781
Domain-

NID2 APEH NID1 SORL1

2.32e-043914542.120.10.30
DomainIntegrin_alpha_C_CS

ITGAD ITGAM ITGAV

2.38e-04161453IPR018184
Domain-

DPP7 NLGN4Y APEH LCAT NLGN4X PRCP

3.33e-0411914563.40.50.1820
DomainAB_hydrolase

DPP7 NLGN4Y APEH LCAT NLGN4X PRCP

3.33e-041191456IPR029058
DomainIntegrin_alpha-2

ITGAD ITGAM ITGAV

3.43e-04181453IPR013649
DomainINTEGRIN_ALPHA

ITGAD ITGAM ITGAV

3.43e-04181453PS00242
DomainIntegrin_alpha2

ITGAD ITGAM ITGAV

3.43e-04181453PF08441
DomainIntegrin_alpha

ITGAD ITGAM ITGAV

3.43e-04181453IPR000413
DomainG2F

NID2 NID1

3.56e-0441452PF07474
DomainNIDOGEN_G2

NID2 NID1

3.56e-0441452PS50993
DomainGFP

NID2 NID1

3.56e-0441452IPR009017
DomainArgonaute_N

AGO2 AGO4

3.56e-0441452IPR032474
DomainArgonaute_Mid_dom

AGO2 AGO4

3.56e-0441452IPR032473
DomainArgoL2

AGO2 AGO4

3.56e-0441452IPR032472
DomainG2_nidogen/fibulin_G2F

NID2 NID1

3.56e-0441452IPR006605
DomainArgoN

AGO2 AGO4

3.56e-0441452PF16486
DomainArgoMid

AGO2 AGO4

3.56e-0441452PF16487
DomainArgoL2

AGO2 AGO4

3.56e-0441452PF16488
DomainInt_alpha

ITGAD ITGAM ITGAV

4.05e-04191453SM00191
DomainInt_alpha_beta-p

ITGAD ITGAM ITGAV

4.05e-04191453IPR013519
DomainAlpha-amylase_C

AMY2A GBE1

5.89e-0451452PF02806
DomainNIDO_dom

NID2 NID1

5.89e-0451452IPR003886
DomainNIDO

NID2 NID1

5.89e-0451452SM00539
DomainNIDO

NID2 NID1

5.89e-0451452PF06119
DomainA-amylase/branching_C

AMY2A GBE1

5.89e-0451452IPR006048
DomainNIDO

NID2 NID1

5.89e-0451452PS51220
DomainNlgn

NLGN4Y NLGN4X

5.89e-0451452IPR000460
DomainBcl2_BH4

BCL2 BCL2L2

5.89e-0451452IPR003093
DomainBH4_2

BCL2 BCL2L2

5.89e-0451452PS50063
DomainDUF1785

AGO2 AGO4

5.89e-0451452SM01163
DomainBH4_1

BCL2 BCL2L2

5.89e-0451452PS01260
DomainFG_GAP

ITGAD ITGAM ITGAV

6.33e-04221453PS51470
DomainCLAUDIN

CLDN18 CLDN7 CLDN19

6.33e-04221453PS01346
DomainClaudin_CS

CLDN18 CLDN7 CLDN19

6.33e-04221453IPR017974
Domainig

KIR2DS2 ADGRF5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

7.16e-041901457PF00047
DomainImmunoglobulin

KIR2DS2 ADGRF5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

7.16e-041901457IPR013151
DomainFG-GAP

ITGAD ITGAM ITGAV

8.23e-04241453PF01839
DomainFG-GAP

ITGAD ITGAM ITGAV

8.23e-04241453IPR013517
DomainArgoL1

AGO2 AGO4

8.80e-0461452PF08699
DomainArgoL1

AGO2 AGO4

8.80e-0461452IPR014811
DomainGlyco_hydro_13

AMY2A GBE1

8.80e-0461452IPR015902
DomainIntegrin_dom

ITGAD ITGAM ITGAV

9.30e-04251453IPR032695
DomainGlyco_hydro_13_cat_dom

AMY2A GBE1

1.23e-0371452IPR006047
DomainAlpha-amylase

AMY2A GBE1

1.23e-0371452PF00128
DomainCupin_4

HSPBAP1 JMJD8

1.23e-0371452PF08007
DomainAamy

AMY2A GBE1

1.23e-0371452SM00642
DomainClaudin

CLDN18 CLDN7 CLDN19

1.30e-03281453IPR006187
DomainPIWI

AGO2 AGO4

1.63e-0381452PS50822
DomainPiwi

AGO2 AGO4

1.63e-0381452SM00950
DomainDHC_N1

DNAH2 DNAH9

1.63e-0381452PF08385
DomainPiwi

AGO2 AGO4

1.63e-0381452PF02171
DomainPiwi

AGO2 AGO4

1.63e-0381452IPR003165
DomainBcl2_BH2_motif_CS

BCL2 BCL2L2

1.63e-0381452IPR020726
DomainBcl2_BH1_motif_CS

BCL2 BCL2L2

1.63e-0381452IPR020717
DomainDynein_heavy_dom-1

DNAH2 DNAH9

1.63e-0381452IPR013594
DomainPAZ

AGO2 AGO4

2.08e-0391452PS50821
DomainPAZ

AGO2 AGO4

2.08e-0391452SM00949
DomainPAZ

AGO2 AGO4

2.08e-0391452PF02170
DomainPAZ_dom

AGO2 AGO4

2.08e-0391452IPR003100
DomainGPS

PKD1 ADGRF5 ADGRD1

2.30e-03341453SM00303
DomainGPCR_2_secretin-like_CS

SCTR ADGRF5 ADGRD1

2.30e-03341453IPR017983
DomainGPS

PKD1 ADGRF5 ADGRD1

2.50e-03351453PF01825
DomainAn_peroxidase

TPO PTGS2

2.59e-03101452PF03098
DomainHaem_peroxidase_animal

TPO PTGS2

2.59e-03101452IPR019791
DomainHaem_peroxidase

TPO PTGS2

2.59e-03101452IPR010255
DomainPEROXIDASE_3

TPO PTGS2

2.59e-03101452PS50292
Domain-

TPO PTGS2

2.59e-031014521.10.640.10
DomainGPS

PKD1 ADGRF5 ADGRD1

2.71e-03361453PS50221
DomainGPS

PKD1 ADGRF5 ADGRD1

2.94e-03371453IPR000203
DomainGFP-like

NID2 NID1

3.14e-03111452IPR023413
DomainPNT

ETS1 ETS2

3.14e-03111452PS51433
DomainSAM_PNT

ETS1 ETS2

3.14e-03111452PF02198
Domain-

NID2 NID1

3.14e-031114522.40.155.10
DomainBH1

BCL2 BCL2L2

3.14e-03111452PS01080
DomainBlc2_fam

BCL2 BCL2L2

3.14e-03111452IPR026298
DomainPointed_dom

ETS1 ETS2

3.14e-03111452IPR003118
DomainSAM_PNT

ETS1 ETS2

3.14e-03111452SM00251
DomainPMP22_Claudin

CLDN18 CLDN7 CLDN19

3.67e-03401453PF00822
DomainGPCR_2_extracellular_dom

SCTR ADGRF5 ADGRD1

3.67e-03401453IPR001879
DomainG_PROTEIN_RECEP_F2_1

SCTR ADGRF5 ADGRD1

3.67e-03401453PS00649
DomainG_PROTEIN_RECEP_F2_3

SCTR ADGRF5 ADGRD1

3.67e-03401453PS50227
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.20e-1210150612559621
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.40e-125150518755860
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.40e-125150516112031
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.70e-1114150619875891
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.70e-1114150619489269
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.70e-1114150615896204
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150617498266
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150620082646
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150620356536
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150619926642
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150620643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.82e-1115150619326408
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.91e-117150511169255
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150619897003
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150619309280
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150616403292
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150620652381
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150617868255
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150620331834
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150619000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150620670355
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150618668235
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150619527230
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150619279038
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150618643961
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.50e-1116150620210919
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150619968064
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150620878400
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150620483367
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150619450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150619761533
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150620650299
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150620173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150620173792
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

6.93e-1117150619218127
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

7.73e-118150518681957
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150620580654
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150620519398
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150619846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150619630074
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150620200544
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.04e-1018150619046302
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.51e-1019150620600442
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.51e-1019150618571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.51e-1019150618778326
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of ParanĂ¡.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.51e-1019150618848853
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

1.73e-10915057749980
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.15e-1020150620193031
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.99e-1021150619861144
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.32e-104150426542066
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.10e-1022150620492596
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.31e-1011150519664392
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.08e-0912150519936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.08e-0912150519181658
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL2

1.08e-0912150520137308
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.08e-0912150520371502
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL2

1.66e-09515047716543
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1

1.66e-095150410424431
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.75e-0913150519934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.75e-0913150519120281
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.75e-0913150518687225
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

2.55e-0929150620082482
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.71e-0914150519421224
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR3DL2

2.71e-0914150518945962
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.05e-0915150519850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.05e-0915150520207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.05e-0915150519493232
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1

4.95e-096150417882223
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

8.28e-0917150519032228
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

8.28e-0917150519169284
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

8.52e-0935150619683555
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

1.14e-0818150520210918
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL2

1.15e-087150414607943
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR3DL2

2.05e-0820150520426625
Pubmed

Genetic polymorphisms associated with priapism in sickle cell disease.

ITGAV F13A1 KL NOS2

2.30e-088150417408468
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL2

2.30e-08815049430221
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

2.30e-088150415730517
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR3DL2

4.12e-08915048662091
Pubmed

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.

KIR2DS2 KIR2DL1 KIR2DS1

7.86e-083150329549293
Pubmed

Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3

7.86e-083150322960345
Pubmed

[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].

KIR2DL1 KIR2DL2 KIR2DL3

7.86e-083150319549382
Pubmed

Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.

KIR2DS2 KIR2DL2 KIR2DS1

7.86e-083150323380384
Pubmed

Imputation of KIR Types from SNP Variation Data.

KIR2DS2 KIR2DL2 KIR2DL3

7.86e-083150326430804
Pubmed

Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.

KIR2DS2 KIR2DL2 KIR2DL3

7.86e-083150318292496
Pubmed

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

KIR2DS2 KIR2DL2 KIR2DL3

7.86e-083150330696053
Pubmed

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.

KIR2DS2 KIR2DL2 KIR2DS1

7.86e-083150319877200
Pubmed

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

KIR2DL1 KIR2DL2 KIR2DL3

7.86e-083150315879158
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3

1.07e-0711150418830515
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL2

1.60e-0712150417490516
Pubmed

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

DPP7 NID2 AMY2A CDHR2 FOLH1 TOM1L1 APEH GBE1 LCAT ITGAM ITGAV ITIH1 LGALS1 KL PRCP NID1 CD81 FUCA2 MASP2

1.98e-0710701501923533145
Pubmed

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.

KIR2DL1 KIR2DL2 KIR2DL3

3.14e-074150320056126
Pubmed

HLA-C and KIR genes in hepatitis C virus infection.

KIR2DL1 KIR2DL2 KIR2DL3

3.14e-074150316571411
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3

3.14e-074150318269867
Pubmed

KIR/HLA ligand incompatibility in kidney transplantation.

KIR2DS2 KIR2DL2 KIR2DL3

3.14e-074150318091530
Pubmed

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

KIR2DL1 KIR2DL2 KIR2DL3

3.14e-074150325037176
Pubmed

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

KIR2DS2 KIR2DL2 KIR2DL3

3.14e-074150316929347
Pubmed

[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].

KIR2DL1 KIR2DL2 KIR2DL3

3.14e-074150318543232
Pubmed

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

KIR2DL1 KIR2DL2 KIR2DL3

7.81e-075150318322206
Pubmed

Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters.

KIR2DL1 KIR2DL2 KIR2DL3

7.81e-075150312121272
Pubmed

Involvement of microRNA in AU-rich element-mediated mRNA instability.

AGO2 PTGS2 AGO4

7.81e-075150315766526
InteractionPRG2 interactions

SEMA6B B4GALNT1 GALNT12 ITGAV LMAN1 PRCP SUN2 JMJD8 SUMF1 TTC17 SORL1

7.55e-0628514611int:PRG2
InteractionKIR2DS3 interactions

KIR2DS2 ALG9 KIR2DL1 KIR2DL2

1.17e-05201464int:KIR2DS3
Cytoband19q13.4

KIR2DS2 MZF1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

8.22e-0979150719q13.4
Cytoband6q24

TAAR2 FUCA2

2.93e-04815026q24
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

4.07e-1018996620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR2DS2 ITGAD ITGAM ITGAV CD81 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

5.98e-053949910471
GeneFamilyCD molecules|Integrin alpha subunits

ITGAD ITGAM ITGAV

1.22e-04189931160
GeneFamilyClaudins

CLDN18 CLDN7 CLDN19

2.60e-0423993488
GeneFamilyArgonaute/PIWI family

AGO2 AGO4

8.13e-048992408
GeneFamilySolute carriers

SLC43A3 SLC6A4 SLC16A2 SLC16A11 SLC5A12 SLC41A1 SLC12A7 SLC38A8

1.47e-03395998752
GeneFamilyBCL2 family

BCL2 BCL2L2

2.59e-03149921057
GeneFamilyDyneins, axonemal

DNAH2 DNAH9

3.83e-0317992536
GeneFamilyImmunoglobulin like domain containing|Semaphorins

SEMA6B SEMA4A

5.29e-0320992736
CoexpressionHOSHIDA_LIVER_CANCER_SUBCLASS_S3

VSIG2 ETS2 LCAT ITIH1 ADH4 SLC16A2 AGXT CD81 PCK2 SORL1

3.29e-0626615010M1286
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

8.94e-06491505M40909
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_DN

ESYT1 SCAMP3 SLC43A3 ZZEF1 SBNO2 ADORA2B SF3B3 LMAN1 CLCN6 ALG9 NID1 UNKL CD81 SLC41A1 ILVBL

9.07e-0668115015M5314
CoexpressionHE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL

DPP7 TMEM45A NLGN4Y GBE1 SLC43A3 ITGAV TPCN1 NLGN4X RASAL3 PDLIM3 MZF1 SUN2 SLC41A1 SLC12A7

1.04e-0560415014M45760
CoexpressionWINTER_HYPOXIA_METAGENE

ETS1 GBE1 BCL2L2 PTGS2 LGALS1 ADORA2B SLC16A2 NOS2 SORL1

1.16e-052431509M14072
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_DN

ESYT1 SCAMP3 SLC43A3 ZZEF1 SBNO2 ADORA2B SF3B3 LMAN1 CLCN6 ALG9 NID1 UNKL CD81 SLC41A1 ILVBL

1.32e-0570315015MM1055
CoexpressionGSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP

SEMA6B B4GALNT1 AGO2 ESYT1 ETS1 BCL2L2 ITIH1 NID1

2.08e-052001508M8844
CoexpressionPDGF_ERK_DN.V1_UP

ACP5 TSPAN5 FCHSD2 LMAN1 CCL25 KIR3DL2 NOS2

2.09e-051451507M2830
CoexpressionLAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX

PSD3 ITGAV CLIP1 FREM1 SUMF1 ATP6V0A4 ADGRF5

2.83e-051521507M39239
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ETS1 BCL2 CD81 KIR2DL1 KIR2DL2 KIR2DL3 BUB3 KIR3DL2

3.14e-071961488cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCell10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue

ETS1 ITGAM SUN2 KIR2DL1 KIR2DL3 KIR3DL2 MVD SORL1

3.14e-0719614881868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

CACNA1D NID2 PSD3 FREM1 ADH4 TMEM132C NID1 CD81

3.67e-072001488a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellE16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass

CLDN18 VSIG2 GALNT12 ESRP2 ADAMTSL5 ATP6V0A4 ADGRF5

8.95e-0715514879cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NLGN4Y APEH SLC43A3 SUMF1 NID1 DECR2 CLDN19

1.60e-061691487e3100eb587005e160bd0b7990fa57ec49765133d
ToppCellfacs-SCAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ACP5 ETS1 BCL2 ITGAD RASAL3 SUN2

1.94e-06174148787fa5deff5c1aabb342d674f05ad17c4c0e50d01
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TEAD2 TMEM45A SLC43A3 KL SLC16A2 CD81 SLC12A7

2.17e-0617714876f6cf93893daac6ae228df36219ee3acf8de8f97
ToppCellRA-17._Lymphocyte|RA / Chamber and Cluster_Paper

ETS1 BCL2 TSPAN5 RASAL3 KIR2DL3 KIR3DL2 SORL1

2.61e-061821487257a7847917b6ea1d60608183d90300bfd028758
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CLDN18 VSIG2 LCN12 TOM1L1 CLDN7 FAM83H ESRP2

2.71e-0618314870cea883a8a79fc58abcb26b08bf5db9d3d60f7d4
ToppCellRA-17._Lymphocyte|World / Chamber and Cluster_Paper

ETS1 BCL2 TSPAN5 RASAL3 KIR2DL3 KIR3DL2 SORL1

2.71e-0618314876397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLII CLDN7 SLC43A3 LGALS1 TPCN1 CD81 FUCA2

2.91e-06185148730b7a738d91f4292d5572a50c352563e8529b8da
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PSD3 CLIP1 TSPAN5 FREM1 ATP6V0A4 ADGRF5 CDYL

3.01e-061861487a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCellfacs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ESYT1 ACP5 ETS1 BCL2 RASAL3 SLC12A7

3.01e-061861487e23e1246914e230369a716d0d666b98383bf8512
ToppCellfacs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ESYT1 ACP5 ETS1 BCL2 RASAL3 SLC12A7

3.01e-0618614874dce1484653bb266e2305cbb306fb11eaf7892e2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PSD3 CLIP1 TSPAN5 FREM1 ATP6V0A4 ADGRF5 CDYL

3.23e-061881487e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCellNS-critical-d_16-33-Lymphoid-CTL|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ETS1 RASAL3 SUN2 OXNAD1 CD81 BUB3 KIR3DL2

3.35e-0618914878a02c40bfc92cee37c4dee7c7bf98ab826f64a14
ToppCellCOVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type

EML4 ETS1 BCL2 TSPAN5 RASAL3 OXNAD1 SORL1

3.59e-0619114875a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCellCOVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type

EML4 ETS1 BCL2 TSPAN5 RASAL3 OXNAD1 SORL1

3.59e-06191148773ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCellwk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NID2 VSIG2 TOM1L1 CLDN7 ESRP2 ADGRF5 CLDN19

3.72e-06192148787b60014202633a4f6d19b09a5dd9276c2edecfb
ToppCellwk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NID2 VSIG2 TOM1L1 CLDN7 ESRP2 ADGRF5 CLDN19

3.72e-061921487fa2420d6117d4800f60ef6a24bcf8bf54593cd1f
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ETS1 ZZEF1 RASAL3 OXNAD1 KIR2DL1 KIR2DL3 SORL1

3.85e-06193148700349d176fb6a46cbcc99c41d975651b6e9aaad4
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ETS1 ITGAD RASAL3 OXNAD1 KIR2DL1 KIR2DL3 KIR3DL2

3.98e-0619414876b5be379074241973220f7ef02ef3d5d7d8428ef
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ITGAM LGALS1 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

3.98e-06194148752e09b14159b609af00264a8f38accf37ba8f464
ToppCellwk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CLDN18 VSIG2 LCN12 TOM1L1 CLDN7 ESRP2 CLDN19

4.12e-06195148745d1acd316d0ced97dfb150c3a943128d8fa4e7e
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.26e-061961487d3bd8fab010e76024d7e06aba0ea5df3394f411f
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.26e-06196148777da6b1bcab45d376eb0368f540e0ed24ce98b42
ToppCellCOVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.26e-061961487cc1daf12de5765ba4f7002396352404b41df2012
ToppCell10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue

ITGAM SUN2 KIR2DL1 KIR2DL3 KIR3DL2 MVD SORL1

4.26e-061961487e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCell10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue

ITGAM SUN2 KIR2DL1 KIR2DL3 KIR3DL2 MVD SORL1

4.26e-061961487a3b077e82b1550eb328c84b567b60179001f9a77
ToppCellCOVID-19_Severe-NK|World / disease group, cell group and cell class

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.26e-061961487f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.40e-0619714879993fdea353abeafc009ac87439ad25cedf8f1f6
ToppCellInfluenza_Severe-NK|World / Disease group and Cell class

ETS1 TSPAN5 RASAL3 CD81 KIR2DL1 KIR2DL3 KIR3DL2

4.40e-061971487565d578f7a28a19175d56663bf30c60e0d5e1b22
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.40e-061971487300849a922722adcbc068593fc5cc0bef936d9cb
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.40e-061971487a8b41fffa4e86f2766423392951ff320e821a19a
ToppCellsevere_influenza-NK|World / disease group, cell group and cell class (v2)

ETS1 TSPAN5 RASAL3 CD81 KIR2DL1 KIR2DL3 KIR3DL2

4.40e-0619714878e86a1ee0418e153d4f0bf291006cffc6cf36f71
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.40e-061971487a97c4a9eb89260b0b5745834ccef9d558d857f93
ToppCellHealthy_donor-NK|World / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.55e-0619814874c9c40e91173836ad0df2eba635a4cb3385e80c6
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 KLHDC4 MVD

4.55e-061981487eb5407908f1e43b5775d50006cc6c71e90b73660
ToppCellmild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL3 KIR3DL2 KLHDC4 SORL1

4.55e-0619814871e43181c13e054570046c7a973ddc1c586e259b0
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

BCL2 ITGAM F13A1 TPCN1 FCHSD2 SEMA4A SORL1

4.55e-0619814877f7024b26337ae2bc7f57c3274a7dfdaaa64ab7c
ToppCellsevere_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.55e-0619814877f51e37516f717e424190e6584f1c74d357e2da4
ToppCellmild_COVID-19-NK|World / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.55e-061981487c0334e31772ab691be29cbaa78e43ee3b00425f5
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ITGAM LGALS1 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.55e-061981487faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0
ToppCellCOVID-19_Severe-NK|COVID-19_Severe / disease group, cell group and cell class

ETS1 RASAL3 SUN2 CD81 KIR2DL3 KIR3DL2 MVD

4.55e-0619814870cb88084eac25604ec8f9b1497fb8d2433f1971c
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 KLHDC4 MVD

4.55e-061981487a89de373e4287a104d4df2c40fb0e406d729b1df
ToppCellSevere_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

SEMA6B EML4 ETS2 ITGAM F13A1 LGALS1 CCDC88A

4.70e-06199148730523cf08815ca214877e33a2c52197ff8318557
ToppCellBAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA6B EML4 ETS2 ITGAM F13A1 LGALS1 CCDC88A

4.70e-061991487b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8
ToppCellmild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.70e-0619914874854f25ee436e1cf577744373ffd87b1221d2b88
ToppCellTransverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass

GBE1 BCL2L2 ZZEF1 F13A1 KL UNKL SLC12A7

4.70e-061991487fd75dccb37d96448edf72b7d042b06833d4ead24
ToppCellBAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SEMA6B EML4 ETS2 ITGAM F13A1 LGALS1 CCDC88A

4.70e-061991487105709b97c55826a852aed27658e3b4af1738c8a
ToppCellBAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA6B EML4 ETS2 ITGAM F13A1 LGALS1 CCDC88A

4.70e-0619914870892957a49304ce4b6daa3657d76d8365ce0dd19
ToppCellHealthy/Control-NK|World / Disease group and Cell class

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.70e-06199148787af9c38938dc2db0f9cf9f3676895d2a8b5d7e6
ToppCellHealthy/Control-NK|Healthy/Control / Disease group and Cell class

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.70e-061991487e7fd91080fca7c31a2d48433791da3c2a4adf14d
ToppCellBAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SEMA6B EML4 ETS2 ITGAM F13A1 LGALS1 CCDC88A

4.70e-061991487961ad44199871be8e09d31904d383edc865ba262
ToppCellHealthy_donor-NK|Healthy_donor / disease group, cell group and cell class (v2)

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.70e-0619914874892d85f7c8c00e5afdcea2cd7bae0074322fa52
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CACNA1D TMEM45A PSD3 FREM1 ADH4 TMEM132C CD81

4.86e-062001487b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CACNA1D TMEM45A PSD3 FREM1 ADH4 TMEM132C CD81

4.86e-06200148750ca6550998e461ef26dd670351060bd940765a8
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ETS1 ITGAD ITGAM RASAL3 KIR2DL1 KIR2DL3 SORL1

4.86e-062001487d2422aaf807010194994db97142b9fd2e807312d
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK|COVID-19_Mild / Disease, condition lineage and cell class

SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 KLHDC4 MVD

4.86e-062001487885fcb6c6c744f89fc983a617303e6f57126d908
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK|COVID-19_Severe / Disease, condition lineage and cell class

ETS1 SUN2 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.86e-0620014872580b7b83ba707718fe23ffca986e7a55ea85bce
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ETS1 ITGAD ITGAM RASAL3 KIR2DL1 KIR2DL3 SORL1

4.86e-06200148756d738ff019682af7f1f8cbe7b262a75dc8596d5
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ETS1 RASAL3 SUN2 KIR2DL1 KIR2DL3 KIR3DL2 SORL1

4.86e-0620014870a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ETS1 ITGAD ITGAM RASAL3 KIR2DL1 KIR2DL3 SORL1

4.86e-0620014877eed3d932018d6a87ce37d013883b371db55caeb
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CACNA1D TMEM45A PSD3 FREM1 ADH4 NID1 CD81

4.86e-06200148744a68bacdb3d5bf563bd35952176995850933a81
ToppCellCOVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class

ITGAM LGALS1 CD81 KIR2DL1 KIR2DL3 KIR3DL2 MVD

4.86e-062001487b586b0f1127293c2f8529be16b24229359041da2
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CACNA1D TMEM45A PSD3 FREM1 ADH4 NID1 CD81

4.86e-062001487dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ETS1 ITGAD ITGAM RASAL3 KIR2DL1 KIR2DL3 SORL1

4.86e-0620014871d2ee63010b7b8b38bea7d3b30eebfbcdd18b967
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D TMPRSS9 PCDHB2 FREM1 ATP6V0A4 AIFM3

6.06e-06135148688f86bab637f1ca1439c7de2d12be4329cf662b8
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D PCDHB2 FREM1 KL ATP6V0A4 AIFM3

7.47e-0614014865e81fa3a19d23f0e9cae3878431ca1f78dff7238
ToppCell10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue

ITGAD OXNAD1 KIR2DL3 CCL25 KIR3DL2 MASP2

1.39e-0515614860ea6ca3f38109151a2a4fdf63a4f009929cdcc40
ToppCellfacs-Lung-EPCAM-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 BCL2 LGALS1 RASAL3 GGCT SEMA4A

1.49e-0515814868844fba9c1e41f062edf3110d025f33b86afb951
ToppCellfacs-Lung-EPCAM-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 BCL2 LGALS1 RASAL3 GGCT SEMA4A

1.49e-051581486c56607cba9a3719ac6d573d970686053e1676985
ToppCellfacs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 BCL2 MS4A15 LGALS1 RASAL3 SEMA4A

1.60e-051601486e4516b093003275084fc327d1597394a436754eb
ToppCellfacs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 BCL2 MS4A15 LGALS1 RASAL3 SEMA4A

1.60e-0516014860a507e3d59d7f744d0201a531ea84fa97a68aedb
ToppCellfacs-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ESYT1 BCL2 LGALS1 RASAL3 SEMA4A

1.66e-05161148633de3e8b3238fcfc66dfbf89a913a07d464d6c35
ToppCellfacs-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ESYT1 BCL2 LGALS1 RASAL3 SEMA4A

1.66e-051611486ae1cee34361dde9964581cca99a29578c3b3bd99
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMS1 BCL2 MS4A15 ITGAM RASAL3 SEMA4A

1.72e-0516214860321fc954ae4ad67ca438cbbc84632562d222188
ToppCellfacs-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 BCL2 MS4A15 LGALS1 RASAL3 SEMA4A

1.72e-05162148604ccd3d216f8f41afd3434a61264f03d6324db35
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMS1 BCL2 MS4A15 ITGAM RASAL3 SEMA4A

1.72e-0516214865731f9514434296132df4bc86f78ce87b07cdeca
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

B4GALNT1 ACP5 LGALS1 RASAL3 GGCT SEMA4A

1.78e-0516314869c91415a56b12b3b2d15d253bb59db8bedf49ea2
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ETS1 BCL2 LGALS1 RASAL3 SEMA4A

1.78e-051631486a0315855c354e830e109d41bd6e3396488aa8de9
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT1 ETS1 BCL2 LGALS1 RASAL3 SEMA4A

1.84e-051641486a59078c8f88e416e940c9b15151ce7de1bbe987e
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ARMCX4 OXNAD1 CLDN19 DNAH9 PCK2 ADGRD1

1.84e-051641486d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8
ToppCellfacs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 F13A1 LGALS1 ADORA2B CCDC88A SEMA4A

2.25e-051701486a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCellfacs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 F13A1 LGALS1 ADORA2B CCDC88A SEMA4A

2.25e-051701486ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 ACP5 ETS1 BCL2 LGALS1 RASAL3

2.25e-051701486f9596088a1a7686467e54eabaad5269f2c5fbfec
ToppCellIonocyte|World / Class top

CACNA1D ZNF365 KL PDLIM3 CD81 ADGRF5

2.25e-051701486d2e592f2a679e6a8d32f2b752d9a3c493e50ced4
ToppCell10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NIPSNAP3B ETS2 ITGAD ESRP2 ZACN CCL25

2.25e-051701486a50e558d0b38100ccbdccb90647fe93e85bffd86
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ACP5 ETS1 ITGAV LGALS1 ADH4 RASAL3

2.33e-0517114864c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc
ToppCelldroplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 ETS1 BCL2 ITGAM LGALS1 SEMA4A

2.33e-051711486834b39b48bf3135dc41e787f5e20ebb234b5d97a
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ACP5 ETS1 ITGAV LGALS1 ADH4 RASAL3

2.33e-051711486c5c1d23b4040a78991512bfcbe046c51f202d2cf
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

ITGAM KIR2DL1 KIR2DL3 KIR3DL2 MVD SORL1

2.41e-051721486701de463f85aaad3a4b36a0d5fbc416406620089
ToppCelldroplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 ETS1 BCL2 ITGAM LGALS1 SEMA4A

2.41e-051721486fdf54ab7ec002d831d8cce2ce5956d644176ca00
ToppCelldroplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALNT1 ETS1 BCL2 ITGAM LGALS1 SEMA4A

2.41e-051721486a749f4ab4048d806a83f1f71a197584b8db833ad
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TTC39B EML4 NUP210L ACP5 CCDC88A CD81

2.57e-051741486d5c22b43531414951666ee7542a66ed9380e2d14
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

F13A1 LGALS1 ADORA2B CCDC88A SUMF1 SEMA4A

2.65e-05175148669b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCelldroplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TEAD2 VSIG2 SHROOM2 FCHSD2 ADGRF5 SLC41A1

2.65e-05175148698dc3b6f69a29d587f503898f09912700950e3d9
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

F13A1 LGALS1 ADORA2B CCDC88A SUMF1 SEMA4A

2.65e-0517514864f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCellfacs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM45A CLIP1 TSPAN5 ELOVL4 ESRP2 GGCT

3.01e-0517914864a072526c3a524a7aed99bdb32a07a1ce1f48972
ToppCelldroplet-Kidney-nan-21m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA6B LCAT ARSG DECR2 FGGY

3.05e-0510814857ef144b8039889c8e883b958c50c121bce972e0d
DrugAa1

DPP7 FCHSD2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL2

1.17e-06831487CID009549188
Drugglycoluril

ITGAV LGALS1 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

1.22e-06531486CID000062347
Drug6-carboxyfluorescein diacetate

ATP6V0A4 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

1.36e-06301485CID000151095
Drug1,2-Dimethylhydrazine

ETS1 BCL2 PTGS2 SLC6A4 NOS2

1.90e-06321485ctd:D019813
Drugzingerone

BCL2 LCAT PTGS2 NOS2

6.16e-06191484ctd:C013738
Drugsalvin

BCL2 BCL2L2 ITGAM PTGS2 NOS2

6.73e-06411485ctd:C018381
Drugarsenic disulfide

BCL2 ITGAM PTGS2 PRCP NOS2 SORL1

8.77e-06741486ctd:C058317
Drugsulphoraphene

BCL2 PTGS2 NOS2

9.24e-0671483ctd:C473643
DrugCNB 001

BCL2 PTGS2 NOS2

9.24e-0671483ctd:C529348
Drugdapoxetine

BCL2 PTGS2 NOS2

1.47e-0581483ctd:C080598
DrugAC1L1DXE

CACNA1D FLII FOLH1 APEH BCL2 PTGS2 OPRL1 SLC6A4 PKD1 NOS2

2.71e-0529914810CID000002548
DrugRgd Peptide

FLII BCL2 ITGAD ITGAM ITGAV FCHSD2 ADAMTSL5 SCTR NID1

2.75e-052391489CID000104802
DrugAC1ODVCS

DPP7 KIR2DL2 KIR2DL3 KIR3DL2

4.12e-05301484CID000111104
DrugN-(3-chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetamide

PTGS2 NOS2

4.20e-0521482ctd:C582844
DrugMycoplasma arthritidis mitogen

PTGS2 NOS2

4.20e-0521482ctd:C052996
Drugperhydrodiazepine

SLC6A4 NOS2

4.20e-0521482CID012680363
Drugdiphenylmethyl selenocyanate

PTGS2 NOS2

4.20e-0521482ctd:C495419
Drug4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate

PTGS2 NOS2

4.20e-0521482ctd:C568824
Drugepitaondiol

PTGS2 AGXT

4.20e-0521482CID000156834
Drugeugenosedin-A

PTGS2 NOS2

4.20e-0521482ctd:C496985
Drugdiisopropylfluorophosphate

DPP7 TMPRSS9 FOLH1 CAMK2A APEH LCAT CLIP1 PTGS2 PRCP MASP2

4.94e-0532114810CID000005936
DrugN-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide

ETS2 BCL2 ITGAV PTGS2

5.35e-05321484ctd:C451426
Drugergolide

BCL2 PTGS2 NOS2

5.67e-05121483CID000185786
Drugbeta-ionone

BCL2 PTGS2 NOS2

5.67e-05121483ctd:C008157
DrugPeptides

BCL2 PTGS2 NOS2

5.67e-05121483ctd:D010455
Drugindole-3-acetyl-l-valine

ITGAD ITGAM ITGAV KIR2DL2 KIR2DL3

6.54e-05651485CID000446641
Diseasefactor XIII deficiency (is_implicated_in)

F13A1 LMAN1

2.37e-0521442DOID:2211 (is_implicated_in)
DiseaseX-24307 measurement

RASAL3 DNAH9

2.37e-0521442EFO_0800871
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

7.07e-0531442OBA_2042107
DiseaseReperfusion Injury

ETS1 BCL2 PTGS2 ADORA2B NOS2

7.71e-05891445C0035126
Diseaseautism spectrum disorder (implicated_via_orthology)

TMPRSS9 NLGN4Y CAMK2A SCAMP3 SLC6A4 NLGN4X

1.05e-041521446DOID:0060041 (implicated_via_orthology)
Diseasenidogen-2 measurement

NID2 NID1

1.41e-0441442EFO_0020608
Diseasepleurisy (biomarker_via_orthology)

PTGS2 NOS2

2.34e-0451442DOID:10247 (biomarker_via_orthology)
DiseaseDermatitis, Allergic Contact

ETS2 BCL2 ITGAM F13A1

3.28e-04671444C0162820
DiseaseCurling Ulcer

PTGS2 NOS2

3.50e-0461442C0010474
DiseaseDuodenal Ulcer

PTGS2 NOS2

3.50e-0461442C0013295
Diseasearteriosclerosis (is_implicated_in)

LCAT PTGS2 F13A1

4.63e-04311443DOID:2349 (is_implicated_in)
Diseasetype 2 diabetes mellitus (biomarker_via_orthology)

BCL2 ITGAM PTGS2 KL NOS2

7.91e-041471445DOID:9352 (biomarker_via_orthology)
DiseasePolycystic Kidney, Autosomal Dominant

ALG9 PKD1

8.33e-0491442C0085413
DiseaseMemory Loss

BCL2 SLC6A4 KL

1.22e-03431443C0751295
DiseaseAge-Related Memory Disorders

BCL2 SLC6A4 KL

1.22e-03431443C0751292
DiseaseMemory Disorder, Spatial

BCL2 SLC6A4 KL

1.22e-03431443C0751294
DiseaseMemory Disorder, Semantic

BCL2 SLC6A4 KL

1.22e-03431443C0751293
DiseaseMemory Disorders

BCL2 SLC6A4 KL

1.22e-03431443C0025261
Diseasecell growth regulator with EF hand domain protein 1 measurement

NID2 NID1

1.26e-03111442EFO_0801461
Diseaseendometriosis (implicated_via_orthology)

BCL2 PTGS2

1.26e-03111442DOID:289 (implicated_via_orthology)
DiseaseMemory impairment

BCL2 SLC6A4 KL

1.30e-03441443C0233794
Diseaseulcerative colitis

VSIG2 CAMK2A ETS1 APEH ZNF365 KPNA7 KIR3DL2

1.33e-033351447EFO_0000729
DiseasePathological accumulation of air in tissues

KL NOS2

1.51e-03121442C0013990
Diseaseintracranial aneurysm (is_implicated_in)

BCL2 PKD1

1.51e-03121442DOID:10941 (is_implicated_in)
Diseasefamilial hyperlipidemia (implicated_via_orthology)

LCAT KL

1.51e-03121442DOID:1168 (implicated_via_orthology)
DiseaseDrugs used in diabetes use measurement

ETS1 BCL2 ZZEF1 KL SCTR SLC16A11

1.62e-032551446EFO_0009924
Diseaseinflammatory bowel disease

VSIG2 CAMK2A ETS1 SCAMP3 ZNF365 SBNO2 KPNA7 KIR3DL2

1.68e-034491448EFO_0003767
DiseaseReactive Hyperemia

PTGS2 NOS2

1.78e-03131442C0178824
Diseasepleurisy (implicated_via_orthology)

PTGS2 NOS2

1.78e-03131442DOID:10247 (implicated_via_orthology)
Diseasehyperglycemia (is_marker_for)

ITGAM ITGAV

1.78e-03131442DOID:4195 (is_marker_for)
DiseaseVenous Engorgement

PTGS2 NOS2

1.78e-03131442C0042484
Diseasepulmonary emphysema (implicated_via_orthology)

PTGS2 KL

1.78e-03131442DOID:9675 (implicated_via_orthology)
DiseaseHypercalcemia

CYP27B1 KL

1.78e-03131442C0020437
DiseaseMilk-Alkali Syndrome

CYP27B1 KL

1.78e-03131442C0026141
DiseaseActive Hyperemia

PTGS2 NOS2

1.78e-03131442C0333233
DiseaseHyperemia

PTGS2 NOS2

1.78e-03131442C0020452
Diseasecardiovascular disease

CACNA1D CYP27B1 FREM1 OPRL1 CLCN6 ALG9 OR10AD1 AGXT

1.88e-034571448EFO_0000319
Diseasegastric ulcer (implicated_via_orthology)

BCL2 PTGS2

2.07e-03141442DOID:10808 (implicated_via_orthology)
Diseaseinsulin metabolic clearance rate measurement, glucose homeostasis measurement

SLC43A3 ZZEF1

2.07e-03141442EFO_0006830, EFO_0006896
Diseasepolycystic kidney disease (implicated_via_orthology)

PTGS2 PKD1

2.07e-03141442DOID:0080322 (implicated_via_orthology)
DiseaseAlcoholic Intoxication, Chronic

AGO2 CAMK2A OPRL1 ADH4 SLC6A4 NLGN4X

2.08e-032681446C0001973
DiseaseAcute Cerebrovascular Accidents

ITGAV PTGS2 NOS2

2.35e-03541443C0751956
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3

2.38e-03151442EFO_0801746
DiseaseNecrosis

DPP7 BCL2 NOS2

2.48e-03551443C0027540
DiseaseCocaine-Related Disorders

AGO2 CAMK2A PRMT6 SLC6A4

2.63e-031171444C0236736
DiseaseAlzheimer's disease (implicated_via_orthology)

BCL2 PTGS2 NOS2

2.75e-03571443DOID:10652 (implicated_via_orthology)
Diseasewaist-hip ratio

DPP7 NID2 BCL2 CLDN7 ZZEF1 OPRL1 ELOVL4 PRMT6 SLC6A4 ADORA2B ALG9 PKD1 NID1 ADGRF5

2.76e-03122614414EFO_0004343
DiseaseWithdrawal Symptoms

OPRL1 SLC6A4 NOS2

2.89e-03581443C0087169
DiseaseLibman-Sacks Disease

ETS1 ITGAM PTGS2

2.89e-03581443C0242380
DiseaseDrug Withdrawal Symptoms

OPRL1 SLC6A4 NOS2

2.89e-03581443C0086189
DiseaseSubstance Withdrawal Syndrome

OPRL1 SLC6A4 NOS2

2.89e-03581443C0038587
DiseaseDepressive disorder

FOLH1 CAMK2A BCL2 PTGS2 SLC6A4 NOS2

3.03e-032891446C0011581
DiseaseGastric ulcer

PTGS2 NOS2

3.44e-03181442C0038358
DiseaseCerebrovascular accident

ITGAV PTGS2 NOS2

3.49e-03621443C0038454
DiseaseCocaine Abuse

AGO2 CAMK2A PRMT6 SLC6A4

3.54e-031271444C0009171
Diseasecystathionine measurement

VSIG2 PSD3

3.83e-03191442EFO_0010474
Diseasepolyunsaturated fatty acid measurement

TTC39B AGO2 PSD3 LCAT

3.95e-031311444EFO_0010733
Diseaseend stage renal disease (implicated_via_orthology)

BCL2 LCAT

4.24e-03201442DOID:783 (implicated_via_orthology)
Diseaseneoplasm of mature B-cells

ETS1 BCL2

4.24e-03201442EFO_0000096
Diseasehearing loss

NID2 TMPRSS9 ITGAM

4.34e-03671443EFO_0004238
DiseaseDiabetes Mellitus, Non-Insulin-Dependent

ETS1 BCL2 KL SCTR NOS2

4.67e-032211445C0011860
Diseasestatus epilepticus (implicated_via_orthology)

BCL2 PTGS2

4.67e-03211442DOID:1824 (implicated_via_orthology)
DiseaseCocaine Dependence

AGO2 CAMK2A PRMT6 SLC6A4

4.87e-031391444C0600427

Protein segments in the cluster

PeptideGeneStartEntry
GPWFFGEIIDGKFGC

TMEM62

496

Q0P6H9
ASVLDDWFPLQGGQG

ESYT1

426

Q9BSJ8
AGFLGAWAPAVHTQG

CCL25

11

O15444
GIKDFSWSPGGNIIA

EIF3B

466

P55884
PFGKGWFAGRNLAVS

B4GALNT1

331

Q00973
VLAFGIGLTPFLGWN

ADORA2B

131

P29275
GPEGVTFSFFWKTQG

ADGRD1

101

Q6QNK2
GVFAAGDAVTFPLAW

AIFM3

461

Q96NN9
NGTFFGGWKSVDSIP

ADH4

321

P08319
VLGVAAGAILGWPFS

ALG9

216

Q9H6U8
LFQGGPNWGRLVAFF

BCL2L2

86

Q92843
PNWGRLVAFFVFGAA

BCL2L2

91

Q92843
TGGSDGFVNIWDPFN

BUB3

251

O43684
ELAGSVGPFTGFWQT

ARSG

311

Q96EG1
FGPALFVGWASAGLA

CLDN19

161

Q8N6F1
PLGGGREVWFGFHQS

AGO4

181

Q9HCK5
AFWGPITPQGTGFLA

BMS1

981

Q14692
VFNFVFWLAGGVILG

CD81

16

P60033
EVEANEGFWFGPGAE

ARMCX4

1726

Q5H9R4
EGFWFGPGAEAVIGS

ARMCX4

1731

Q5H9R4
PLGGGREVWFGFHQS

AGO2

191

Q9UKV8
GFQPPEGGFGWVVVF

SLC16A2

91

P36021
VFVWGFSFSGALGVP

RCC1L

61

Q96I51
NVPVWDIGGFTLLDG

RASAL3

131

Q86YV0
VGFFLLQGAWPHEGV

KIR2DS2

11

P43631
VGFFLLQGAWPLMGG

KIR3DL2

11

P43630
ATEPGLFGVWAHNGE

PCDHB2

611

Q9Y5E7
ATEPGLFGVWAHNGE

PCDHB18P

556

Q96TA0
GEGWGFVPSDRALVF

AMY2A

296

P04746
VQGAAHFGPVWLASF

CYP27B1

66

O15528
GPGTGIAPFRSFWQQ

NOS2

981

P35228
QGDFPPGGFWALSND

NTM-AS1

66

Q6ZSK4
VGTAWFFGLINGIFL

OR10AD1

146

Q8NGE0
AVWALGNIAGDGPEF

KPNA7

176

A9QM74
VGFFLLQGAWPHEGV

KIR2DL2

11

P43627
GLLAGFGWALVFAPA

SLC16A11

136

Q8NCK7
PGWIDNFNGPSGLFI

FAR1

241

Q8WVX9
EGEEPENFFWVGIGA

FLII

1136

Q13045
GGAWGTEQREAVFPF

LGALS1

66

P09382
GFGGPVFSWRDQAVL

ITIH1

756

P19827
VGFFLLQGAWPHEGV

KIR2DL3

11

P43628
GEWFVLGLAGNSFRP

LCN12

41

Q6JVE5
IGIKWVAGGQAFFGA

ELOVL4

171

Q9GZR5
WVFGGIDPQSGAAVV

FOLH1

381

Q04609
WVKTFGPLAAGNGTN

CCDC88A

21

Q3V6T2
LAGYTGSGPIQLWQF

ETS1

326

P14921
GHFLWPGFGENARVL

PCK2

541

Q16822
QAFFSPWTLLRGGGL

TPO

521

P07202
PAVVAFSQGSVGFLW

NID1

216

P14543
GFTGSGPIQLWQFLL

ETS2

356

P15036
ELNGFPLNSGGTFSW

FREM1

826

Q5H8C1
GGPALWGDAFERAIN

NIPSNAP3B

156

Q9BS92
VADGGAWLTFPNGVK

DECR2

266

Q9NUI1
NIVFSNGELDPWSGG

PRCP

421

P42785
NQGPFWLVLSTGGAA

PDZD3

241

Q86UT5
QGLEGPVFGSADLWN

LMAN1

131

P49257
PVFGSADLWNGVGIF

LMAN1

136

P49257
EFVAAVWHGFPPGSN

MVD

321

P53602
WKPSTFGGEVGFQII

PTGS2

531

P35354
LPVGFGGWQAVDSTP

F13A1

386

P00488
GGIATIFQSPGDEVW

GGCT

66

O75223
GAFAGYWNVTLIPEG

ADAMTSL5

211

Q6ZMM2
GFSADSQWQPILFGV

OR9G4

31

Q8NGQ1
PWGRFGAALTVLGDV

ITGAD

516

Q13349
QWVDFFIPGVSVVGG

OXNAD1

96

Q96HP4
GWLFALEKPGSENGF

NID2

591

Q14112
LRWIEENVGAFGGDP

NLGN4Y

231

Q8NFZ3
GIFIHWGVFSVPSFG

FUCA2

56

Q9BTY2
DPVFWESQGGAQGLK

GASK1A

531

Q9UFP1
FGFPGRNGQESTLWI

HSPBAP1

151

Q96EW2
PGWFDIGADGVIRVN

CDHR2

286

Q9BYE9
SGIQFGSWGSFQLPG

CLCN6

296

P51797
GSWGSFQLPGLLNFG

CLCN6

301

P51797
WAPGAEGVFLTGDFN

GBE1

91

Q04446
EGVFLTGDFNGWNPF

GBE1

96

Q04446
VAFPGWFIAVSSEGG

IL36A

121

Q9UHA7
PDAEVWCLFGDGAFG

ILVBL

511

A1L0T0
GKGLVSQVFWPGTFT

CDYL

516

Q9Y232
VPGFWLNEGGQSVTG

FGGY

321

Q96C11
ADRVLLGGPGSFYWQ

ITGAV

196

P06756
SGEPQIGGFDWRLVF

GALNT12

271

Q8IXK2
HGFAIWFQVTFPGGE

PRMT6

286

Q96LA8
EGGVPFWGGACFIIS

MS4A15

106

Q8N5U1
FPWQVLILGGTTAAG

MASP2

456

O00187
GGQLWVFGGEFASPN

KLHDC4

131

Q8TBB5
LFQGTFPDGFLWAVG

KL

56

Q9UEF7
FIDGFISLGAPWGGS

LCAT

226

P04180
GFQVFGVWPEGSDGT

EML4

776

Q9HC35
FGIINPATGEWKDGL

DNAH9

2191

Q9NYC9
GFWEGEFNGRIGVFP

FCHSD2

606

O94868
WEVSGGQQALPGVSF

C1orf127

81

Q8N9H9
ELDLGWPLTFGFQGT

FAM83H

106

Q6ZRV2
GGVFAPQIFANTGWP

DNAH2

176

Q9P225
GIPGAASGVFLENLW

SLC12A7

366

Q9Y666
LFVLQAIGIPGWGFS

SCAMP3

246

O14828
FGAALFVGWVAGGLT

CLDN18

171

P56856
VGFFLLQGAWPHEGV

KIR2DL1

11

P43626
LRWIEENVGAFGGDP

NLGN4X

231

Q8N0W4
GWVGPNGGITNFDNF

CACNA1D

336

Q01668
IFSNGNLDPWAGGGI

DPP7

411

Q9UHL4
FLGETQFAPGQWAGI

CLIP1

76

P30622
PGFLGFTVQPGNRWS

NUP210L

356

Q5VU65
FVAAGSSVPFWGQLA

PKD1

1816

P98161
VGFFLLQGAWPHEGV

KIR2DS1

11

Q14954
FQGTDILLGFWPFGN

OPRL1

106

P41146
PGDSFLVGANGIWGQ

AGXT

96

P21549
KGGTWEFLQAPAFTG

SORL1

446

Q92673
NFIKTWSQGFPGGVD

TOM1L1

121

O75674
WTDFPGRVLDVGFVG

TIMM29

156

Q9BSF4
VLTQFVSEGAGPWGQ

TMEM132C

581

Q8N3T6
FLIGDQEPWAFRGGL

OGA

671

O60502
QEPWAFRGGLAGEFQ

OGA

676

O60502
GRNQTFGGGVPLFWT

FAM120AOS

126

Q5T036
PTQGAVFVGFSGGVW

SEMA4A

476

Q9H3S1
VFVGFSGGVWRVPRA

SEMA4A

481

Q9H3S1
FLSFLGGIRWGFALP

TMEM69

136

Q5SWH9
LVEVQLSGGAPWGFT

SHROOM2

26

Q13796
LGIWGEGTPFRNFEE

SBNO2

436

Q9Y2G9
IAAVVFGWIPDGHFS

SLC41A1

196

Q8IVJ1
LGFAGVLFGWPSLVF

SLC43A3

21

Q8NBI5
APWGFRLSGGIDFNQ

PDLIM3

11

Q53GG5
QASELFQFWSGGSGP

TEAD2

156

Q15562
WPGSLVVLFGATAGA

ESRP2

26

Q9H6T0
PWGRFGAALTVLGDV

ITGAM

516

P11215
EQQAWFGFAGTPGYL

CAMK2A

166

Q9UQM7
GLLNFPWAFSKAGGV

SLC38A8

41

A6NNN8
FFEQGGWSFLEPEGE

SUPT16H

916

Q9Y5B9
WQGEFPVTNTGEDGF

SUMF1

261

Q8NBK3
PGQAFWAPGDAGVVF

APEH

246

P13798
TWGFGLTTVFPGTNL

ADGRF5

1231

Q8IZF2
GVNWGRIVAFFEFGG

BCL2

141

P10415
FVAPVGHSGIWSFGV

ANKHD1

2391

Q8IWZ3
FGPAIFIGWAGSALV

CLDN7

161

O95471
AGPWGNQTVVFLGSE

SEMA6B

436

Q9H3T3
GGPQFAEVFVIVWFG

YIPF6

116

Q96EC8
RAGVGSEFPAWFLGG

TTC39B

46

Q5VTQ0
NFGLLNSNWGAVPFG

TRMT61B

176

Q9BVS5
QFPAWISQFLARGGG

SUN2

456

Q9UH99
QGFVAFGWGSPAIFV

SCTR

256

P47872
PSGRFFLAGIVSWGI

TMPRSS9

396

Q7Z410
GGFGAASGEVPWQVS

TMPRSS9

506

Q7Z410
LRFVAVGDWGGVPNA

ACP5

26

P13686
LCWSVPGAFAFGVVF

TAAR2

166

Q9P1P5
EFQQAWPLEGFGGAL

TTC17

781

Q96AE7
IFGAPKAGNGQWASV

SF3B3

851

Q15393
GLNGVPGSIWDFVSG

UNKL

526

Q9H9P5
GLGPVEYLSSGWNLF

TPCN1

496

Q9ULQ1
GWGGIVGVFIIFAVF

ATP6V0A4

771

Q9HBG4
GFQGTAAIWPSLFNV

ZACN

26

Q401N2
GFNVIFWFLGITFLG

TSPAN5

21

P62079
LGGFDPVWLFLVVGG

TSPAN5

56

P62079
GAPGEVGSVLFSLFW

ZZEF1

951

O43149
GGFGPISNWGPEIFT

STRCP1

1641

A6NGW2
GFSQIWVLFPFCGGT

ZNF365

131

Q70YC4
LGIVFPFVNWKGALG

SLC5A12

426

Q1EHB4
WIDAAAQIFFSLGPG

SLC6A4

326

P31645
VGDSFALEWSFVQPG

VSIG2

51

Q96IQ7
GHALPGTFFFIIGLW

TMEM45A

6

Q9NWC5
GTPEIAFWGSNAGVK

PSD3

536

Q9NYI0
SFGIAGAGSGVPFHW

JMJD8

166

Q96S16
LWHEEAGGIFSPGFA

MZF1

246

P28698